CalciMedica files prospectus supplement for up to $25 million at-the-market stock offering

• CalciMedica launched an at-the-market equity program to sell up to $25 million of common stock.
• Sales may occur from time to time under its existing equity distribution agreement with H.C. Wainwright.
• The offering uses the company’s effective Form S-3 shelf registration statement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-409049), on September 30, 2026, and is solely responsible for the information contained therein.